We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
Turnover
90.24%
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
+9.1%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.1%
AUM
$403M
AUM Growth
+$250M
(+164%)
Cap. Flow
+$235M
Cap. Flow
% of AUM
58.3%
Top 10 Holdings %
Top 10 Hldgs %
6.29%
Holding
793
New
457
Increased
87
Reduced
29
Closed
219
Avg Time Held
0.1
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$2.8M |
| 2 |
Target
TGT
|
+$2.73M |
| 3 |
Lockheed Martin
LMT
|
+$2.7M |
| 4 |
Dollar Tree
DLTR
|
+$2.53M |
| 5 |
Northrop Grumman
NOC
|
+$2.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$2.59M |
| 2 |
Apple
AAPL
|
+$2.41M |
| 3 |
Conagra Brands
CAG
|
+$1.87M |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.67M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.61% |
| 2 | Consumer Discretionary | 19.21% |
| 3 | Industrials | 13.4% |
| 4 | Healthcare | 12.85% |
| 5 | Financials | 10.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
501
Acco Brands
ACCO
$417M
| $214K | 0.05% |
+16,400
| New | +$192K |
2016 Q4
0 quarters
|
|
502
DELISTED
Avanos Medical
AVNS
| $214K | 0.05% |
+5,800
| New | +$207K |
2016 Q4
0 quarters
|
|
503
DELISTED
Paramount Global Class B
PARA
| $213K | 0.05% |
+3,350
| New | +$199K |
2016 Q4
0 quarters
|
|
504
Tronox
TROX
$554M
| $213K | 0.05% |
+20,700
| New | +$207K |
2016 Q4
0 quarters
|
|
505
Visteon
VC
$2.33B
| $213K | 0.05% |
+2,653
| New | +$199K |
2016 Q4
0 quarters
|
|
506
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $213K | 0.05% |
+14,110
| New | +$199K |
2016 Q4
0 quarters
|
|
|
MDSO
507
DELISTED
Medidata Solutions, Inc.
MDSO
| $213K | 0.05% |
+4,293
| New | +$223K |
2016 Q4
0 quarters
|
|
508
FIVE9
FIVN
$2.41B
| $212K | 0.05% |
+14,964
| New | +$216K |
2016 Q4
0 quarters
|
|
509
Piper Sandler
PIPR
$4.57B
| $211K | 0.05% |
+11,620
| New | +$183K |
2016 Q4
0 quarters
|
|
510
Onity Group
ONIT
$214M
| $211K | 0.05% |
2,607
+1,020
| +64% | +$71.9K |
2016 Q3
1 quarter
|
|
511
Kratos Defense & Security Solutions
KTOS
$7.59B
| $210K | 0.05% |
28,421
+10,421
| +58% | +$70.3K |
2016 Q3
1 quarter
|
|
512
Kulicke & Soffa
KLIC
$4.11B
| $209K | 0.05% |
+13,100
| New | +$191K |
2016 Q4
0 quarters
|
|
513
TechnipFMC
FTI
$27.3B
| $207K | 0.05% |
+7,837
| New | +$196K |
2016 Q4
0 quarters
|
|
514
Berkshire Hathaway Class B
BRK.B
$1.14T
| $206K | 0.05% |
+1,263
| New | +$194K |
2016 Q4
0 quarters
|
|
515
AtriCure
ATRC
$2.85B
| $204K | 0.05% |
+10,400
| New | +$188K |
2016 Q4
0 quarters
|
|
516
Citizens Financial Group
CFG
$26.7B
| $204K | 0.05% |
+5,725
| New | +$173K |
2016 Q4
0 quarters
|
|
517
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $204K | 0.05% |
+7,600
| New | +$199K |
2016 Q4
0 quarters
|
|
518
DELISTED
Denny's
DENN
| $203K | 0.05% |
+15,799
| New | +$184K |
2016 Q4
0 quarters
|
|
|
LHCG
519
DELISTED
LHC Group LLC
LHCG
| $203K | 0.05% |
+4,434
| New | +$180K |
2016 Q4
0 quarters
|
|
|
WMGI
520
DELISTED
Wright Medical Group Inc
WMGI
| $203K | 0.05% |
8,851
-2,449
| -22% | -$57K |
2016 Q1
3 quarters
|
|
521
Cerus
CERS
$439M
| $202K | 0.05% |
+46,400
| New | +$241K |
2016 Q4
0 quarters
|
|
|
ALEX
522
DELISTED
Alexander & Baldwin
ALEX
| $201K | 0.05% |
+4,478
| New | +$187K |
2016 Q4
0 quarters
|
|
523
BlackBerry
BB
$4.73B
| $201K | 0.05% |
+29,200
| New | +$217K |
2016 Q4
0 quarters
|
|
524
Devon Energy
DVN
$55.8B
| $201K | 0.05% |
+4,400
| New | +$194K |
2016 Q4
0 quarters
|
|
525
Pricesmart
PSMT
$5.24B
| $201K | 0.05% |
+2,408
| New | +$212K |
2016 Q4
0 quarters
|
|
Similar funds
MCM
MFG
AFW
HSM
FWM
PIA
CCP
WCM
Bayesian Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Bayesian Capital Management held 793 positions worth $403M, up 164% from $152M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Bayesian Capital Management deployed $235M of net new capital in Q4 2016, opening 457 new positions and adding to 87 existing holdings. Its largest new stake was Procter & Gamble: 32,800 shares worth $2.76M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Zebra Technologies, an estimated $419K trimmed.
- Bayesian Capital Management's largest Q4 2016 buy was Procter & Gamble: 32,800 shares worth $2.76M.
- Bayesian Capital Management added most to Ross Stores in Q4 2016, an estimated $1.85M increase.
- Bayesian Capital Management's biggest Q4 2016 reduction was Zebra Technologies, cutting an estimated $419K.
- Bayesian Capital Management fully exited Adobe in Q4 2016, selling an estimated $2.59M.
- Bayesian Capital Management's ten largest holdings make up 6.3% of its $403M portfolio in Q4 2016.
- Bayesian Capital Management opened 457 new positions and closed 219 in Q4 2016.
- Bayesian Capital Management's portfolio value rose 164% quarter-over-quarter to $403M.
Based on Bayesian Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.